JPRN-UMIN000007001Completed未知
Alternating Chemotherapy and Radiotherapy in Advanced Laryngeal Cancers - Alternating Chemotherapy and Radiotherapy in Advanced Laryngeal Cancers
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Aichi Cancer Center
- Enrollment
- 26
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Previously treated patients 2)A history of radiation therapy 3)Serious complication 4)A history of cerebral infarction
Investigators
Similar Trials
Completed
Not Applicable
Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancerlocally advenced tongue cancerJPRN-UMIN000032732Department of radiation oncology, Southern Tohoku Proton Therapy Center30
Not yet recruiting
Phase 2
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with limited metastatic disease - TNT-OES-1 TRIAesophageal cancerNL-OMON49762Erasmus MC, Universitair Medisch Centrum Rotterdam20
Recruiting
Not Applicable
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with oligometastatic diseaseNL-OMON23939Erasmus MC20
Active, not recruiting
Phase 1
Chemotherapy followed by chemoradiotherapy for metastatic esophageal cancerPatients (18 – 75 years) who are diagnosed with adenocarcinoma of the oesophagus or GOJ with a resectable primary tumour and de-novo synchronous oligometastatic disease.EUCTR2020-003605-55-NLErasmus MC - University Medical Centre20
Active, not recruiting
Not Applicable
ow-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study - NDadvanced and/or metastatic NSCLCMedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2008-003690-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI